The present review aims to highlight the recent research progress that has been made in the field of the transcription factor Nrf2 (nuclear erythroid factor 2 like 2) with reference to its role in the development of type 2 diabetes, obesity and metabolic syndrome and its potential use as a therapeutic target. This evidence concerns the gene NFE2L2 and obesity disorder.